A THC-Isomer Method Quantified Parent Drugs but Only Qualitatively Confirmed Metabolites
A laboratory method can quantify THC while reporting its metabolites only qualitatively. Reber and colleagues developed an isomer-separating method with different reporting scopes for parent THC and carboxy-THC metabolites; a positive metabolite identification was not automatically a numerical concentration.
Separate the analyte from the reporting task
The method addressed delta-8 and delta-9 THC isomers, whose similar chemical structures can complicate identification. It quantified the parent THC isomers in blood and qualitatively confirmed their carboxy metabolites in blood and urine.
Those are separate analytical claims. Quantitation estimates an amount within a validated range. Qualitative confirmation addresses identity under specified criteria. Neither label should be transferred to another analyte simply because it appears in the same report.
Why isomer separation changes interpretation
An unresolved signal cannot safely be assigned to delta-9 THC merely because that is the expected compound. The study used an enhanced LC–MS-MS technique to address the distinction. Its contribution was analytical discrimination, rather than a demonstration of impairment.
A metabolite confirmation also cannot supply a parent-drug concentration. Blood and urine are different specimens, and the carboxy metabolite result addresses a different part of the exposure history.
Read the laboratory conclusion literally
A useful review identifies the specimen, exact isomer, analyte and whether the laboratory reported a concentration or an identification. If the result is qualitative, do not manufacture a number from a peak or a positive label.
Even a properly quantified blood THC result requires separate reasoning about functional effects. Method validation establishes what an assay can report under its tested conditions; it does not establish how a particular person drove.
Related: Why the blood fraction matters for THC interpretation.
Research cited
Reber JD; Karschner EL; Seither JZ; et al.; Journal of Analytical Toxicology; 2022. An Enhanced LC–MS-MS Technique for Distinguishing Delta-8- and Delta-9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens.
